Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation
Institute for Clinical and Experimental Medicine
Institute for Clinical and Experimental Medicine
National Cancer Center, Korea
Fujian Cancer Hospital
The Royal Wolverhampton Hospitals NHS Trust
Dr. Lutfi Kirdar Kartal Training and Research Hospital
Lahore General Hospital
NHS Lothian
Henan Cancer Hospital
N.N. Alexandrov National Cancer Centre
Institut National de la Santé Et de la Recherche Médicale, France
Azienda USL Reggio Emilia - IRCCS
Turku University Hospital
Ankara Etlik City Hospital
Västernorrland County Council, Sweden
National Cancer Center, Korea
Shanghai Public Health Clinical Center
Sykehuset Telemark
East and North Hertfordshire NHS Trust
Region Västerbotten
Linkoeping University
Turku University Hospital
Anhui Provincial Hospital
Ministry of Science and Technology of the People´s Republic of China
Turku University Hospital
Henan Cancer Hospital
University Hospital, Angers
Anhui Provincial Hospital
Anhui Provincial Hospital
South Metropolitan Health Service
Sanpasitthiprasong Hospital
Hull University Teaching Hospitals NHS Trust
Anhui Provincial Hospital
Turku University Hospital
Slovak Academy of Sciences
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Mersin Training and Research Hospital
Turku University Hospital
Anhui Provincial Hospital
Medical Research Council
Turku University Hospital
National Cancer Center, Korea
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Azienda USL Reggio Emilia - IRCCS
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Gulhane Training and Research Hospital
Turku University Hospital
National Cancer Center, Korea
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Turku University Hospital
Turku University Hospital